The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Guest Editorial

Study finds no correlation between cancer burden in catchment areas and cancer centers’ CCSG funding

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

When the idea of looking at cancer center funding and the cancer burden of cancer center catchment areas came to us in the summer of 2024, we lived in a different context. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Byline
Todd Burus, PhD
Data scientist, Markey Cancer Center
Caree McAfee, MA, CHES
Administrative director, Operations and Evaluation, Markey Cancer Center
Pamela C. Hull, PhD
Professor, University of Kentucky, Associate director, Population Science and Community Impact, Markey Cancer Center
Table of Contents

YOU MAY BE INTERESTED IN

Clinical Roundup

Cancer biosimilars associated with lower costs for insurers and patients, UCLA study finds

Biologic drugs play an important role in treating cancers such as breast cancer and lymphoma, but their high costs can add to the financial burden of cancer care. Now, lower-cost versions known as biosimilars are gaining ground, and a study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center suggests their growing use is associated with lower costs for both insurers and patients.
Byline
Todd Burus, PhD
Data scientist, Markey Cancer Center
Caree McAfee, MA, CHES
Administrative director, Operations and Evaluation, Markey Cancer Center
Pamela C. Hull, PhD
Professor, University of Kentucky, Associate director, Population Science and Community Impact, Markey Cancer Center
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account